Co-Existent Probable RBD and PD: Disease Progression, Medication Response, and Clinical Trial Implications.
作者信息
Zou Haotian, Guo Yuanyuan, Goetz Christopher G, Mestre Tiago A, Stebbins Glenn T, Al-Hajraf Falah, Lawton Michael, Hu Michele, Luo Sheng
机构信息
Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA.
出版信息
Mov Disord Clin Pract. 2024 Mar;11(3):312-314. doi: 10.1002/mdc3.13890. Epub 2023 Dec 9.
Abstract
摘要
相似文献
1
Co-Existent Probable RBD and PD: Disease Progression, Medication Response, and Clinical Trial Implications.共存的可能的RBD和PD：疾病进展、药物反应及临床试验意义
Mov Disord Clin Pract. 2024 Mar;11(3):312-314. doi: 10.1002/mdc3.13890. Epub 2023 Dec 9.
2
REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease.REM 行为障碍可预测帕金森病的运动进展和认知下降。
Neurology. 2018 Sep 4;91(10):e894-e905. doi: 10.1212/WNL.0000000000006134. Epub 2018 Aug 8.
3
Factors related to clinically probable REM sleep behavior disorder in Parkinson disease.与帕金森病患者 REM 睡眠行为障碍临床可能相关的因素。
Parkinsonism Relat Disord. 2010 Feb;16(2):105-8. doi: 10.1016/j.parkreldis.2009.08.005. Epub 2009 Aug 27.
4
REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia.快速眼动睡眠行为障碍可预测无痴呆帕金森病患者的认知障碍。
Neurology. 2007 Nov 6;69(19):1843-9. doi: 10.1212/01.wnl.0000278114.14096.74.
5
Clinical implication of REM sleep behavior disorder in Parkinson's disease.帕金森病 REM 睡眠行为障碍的临床意义。
J Parkinsons Dis. 2014;4(2):237-44. doi: 10.3233/JPD-130293.
6
Probable rapid eye movement sleep behavior disorder, nocturnal disturbances and quality of life in patients with Parkinson's disease: a case-controlled study using the rapid eye movement sleep behavior disorder screening questionnaire.可能的快速眼动睡眠行为障碍、帕金森病患者的夜间障碍和生活质量：使用快速眼动睡眠行为障碍筛查问卷的病例对照研究。
BMC Neurol. 2013 Feb 9;13:18. doi: 10.1186/1471-2377-13-18.
7
Effects of Rotigotine on REM Sleep Behavior Disorder in Parkinson Disease.罗替戈汀对帕金森病快速眼动睡眠行为障碍的影响。
J Clin Sleep Med. 2016 Oct 15;12(10):1403-1409. doi: 10.5664/jcsm.6200.
8
The Metabolic Pattern of Idiopathic REM Sleep Behavior Disorder Reflects Early-Stage Parkinson Disease.特发性 REM 睡眠行为障碍的代谢模式反映了帕金森病的早期阶段。
J Nucl Med. 2018 Sep;59(9):1437-1444. doi: 10.2967/jnumed.117.202242. Epub 2018 Feb 23.
9
Differences in clinical characteristics when REM sleep behavior disorder precedes or comes after the onset of Parkinson's disease.快速眼动睡眠行为障碍先于或后于帕金森病发病时的临床特征差异。
J Neurol Sci. 2017 Nov 15;382:58-60. doi: 10.1016/j.jns.2017.08.3247. Epub 2017 Sep 14.
10
REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease.帕金森病中的快速眼动睡眠行为障碍和无张力快速眼动睡眠
Neurology. 2002 Aug 27;59(4):585-9. doi: 10.1212/wnl.59.4.585.
引用本文的文献
1
Assessing tilavonemab efficacy in early Alzheimer's disease via longitudinal item response theory modeling.通过纵向项目反应理论建模评估替拉沃单抗在早期阿尔茨海默病中的疗效。
Alzheimers Dement (N Y). 2024 Jun 4;10(2):e12471. doi: 10.1002/trc2.12471. eCollection 2024 Apr-Jun.
本文引用的文献
1
Using Movement Disorder Society Unified Parkinson's Disease Rating Scale Parts 2 and 3 Simultaneously: Combining the Patient Voice with Clinician Ratings.同时使用运动障碍学会统一帕金森病评定量表第 2 部分和第 3 部分：将患者声音与临床医生评分相结合。
Mov Disord. 2023 Mar;38(3):453-463. doi: 10.1002/mds.29308. Epub 2023 Jan 9.
2
Dissecting the Domains of Parkinson's Disease: Insights from Longitudinal Item Response Theory Modeling.剖析帕金森病的领域：来自纵向项目反应理论建模的见解。
Mov Disord. 2022 Sep;37(9):1904-1914. doi: 10.1002/mds.29154. Epub 2022 Jul 16.
3
Longitudinal Changes in Parkinson's Disease Symptoms with and Without Rapid Eye Movement Sleep Behavior Disorder: The Oxford Discovery Cohort Study.伴有和不伴有快速眼动睡眠行为障碍的帕金森病症状的纵向变化：牛津发现队列研究。
Mov Disord. 2021 Dec;36(12):2821-2832. doi: 10.1002/mds.28763. Epub 2021 Aug 26.
4
REM sleep behaviour disorder: prodromal and mechanistic insights for Parkinson's disease.快速眼动睡眠行为障碍：帕金森病的前驱期和发病机制见解。
J Neurol Neurosurg Psychiatry. 2017 May;88(5):445-451. doi: 10.1136/jnnp-2016-314471. Epub 2016 Dec 13.
5
Interpreting patient-reported outcome results: US FDA guidance and emerging methods.解读患者报告的结局结果：美国 FDA 指南和新兴方法。
Expert Rev Pharmacoecon Outcomes Res. 2011 Apr;11(2):163-9. doi: 10.1586/erp.11.12.
Zotero 插件